Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000410499 | SCV000488989 | likely benign | Li-Fraumeni syndrome 1 | 2016-07-28 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000581715 | SCV000691682 | benign | Hereditary cancer-predisposing syndrome | 2016-04-20 | criteria provided, single submitter | clinical testing | |
National Health Laboratory Service, |
RCV002225388 | SCV002505060 | likely benign | Hereditary breast ovarian cancer syndrome | 2022-04-19 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000581715 | SCV002582229 | likely benign | Hereditary cancer-predisposing syndrome | 2022-06-18 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000410499 | SCV002582791 | likely benign | Li-Fraumeni syndrome 1 | 2022-06-18 | criteria provided, single submitter | clinical testing | |
KCCC/NGS Laboratory, |
RCV000410499 | SCV005881388 | benign | Li-Fraumeni syndrome 1 | 2025-02-01 | criteria provided, single submitter | clinical testing | |
ITMI | RCV000122180 | SCV000086395 | not provided | not specified | 2013-09-19 | no assertion provided | reference population | |
Prevention |
RCV003925215 | SCV004737841 | likely benign | TP53-related disorder | 2019-09-17 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |